US Patent Litigations are now available. Check here

Explore Napp Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2425821May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
EP2425824May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
EP1731152May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine3